FDA — authorised 30 March 1995
- Application: NDA020411
- Marketing authorisation holder: FERRING PHARMS INC
- Local brand name: CERVIDIL
- Indication: INSERT, EXTENDED RELEASE — VAGINAL
- Status: approved
FDA authorised Prostaglandin E2 (Prostin) on 30 March 1995
Yes. FDA authorised it on 30 March 1995.
FERRING PHARMS INC holds the US marketing authorisation.